Abstract

Biofeedback and anal electrostimulation are considered to be established techniques for the treatment of chronic fecal incontinence when the involuntary loss of stool cannot be stopped by surgery, by general measures such as optimizing stool consistency, or by the treatment of an underlying proctological condition. In fact the terms “biofeedback” and “electrical stimulation” cover a wide range of therapies, which have been subjected to varying methods of evaluation. The available literature on the subject does not allow a systematic comparison of different forms of treatment (1). No general recommendation to treat fecal incontinence in any particular way can be derived from the individual studies published to date (2). Despite this, certain types of treatment without any clear evidence of efficacy are now reimbursable by the statutory health insurance carriers in Germany, while others cannot be ordered. The frequent result is a fruitless struggle with the Medical Service of Health Insurance Companies in Germany (Medizinischer Dienst der Krankenversicherung, MDK) and with the statutory health insurance carriers (Gesetzliche Krankenversicherungen, GKV), ending in the refusal of payment for indicated treatment. Such conflicts are annoying, and the denial of treatment for our patients is regrettable. Yet there is a real lack of evidence-based treatment due to the inadequacy of scientific study in this area.

Highlights

  • This editorial accompanies the article “Triple-Target Treatment vs. Low-Frequency Electrostimulation for Anal Incontinence: A Randomized, Controlled Trial,” by Thilo Schwandner, Claudia Hemmelmann, et al, which appears on the following pages

  • Thilo Schwandner and colleagues have carried out a systematic investigation of various methods of anal electrostimulation to treat fecal incontinence

  • In a trial whose findings were published last year (3), the authors compared treatment with electromyographically triggered biofeedback training (EMG-BF) to a type of multimodal treatment that they call tripletarget treatment (TTT or 3T), consisting of EMG-BF combined with amplitude-modulated mediumfrequency anal electrosimulation (AM-MF)

Read more

Summary

Heinz Becker and Stephan Samel

A Randomized, Controlled Trial,” by Thilo Schwandner, Claudia Hemmelmann, et al, which appears on the following pages. Klinik für Allgemeinund Viszeralchirurgie, Georg-AugustUniversität, Göttingen: Prof.

Praxis für Koloproktologie und chirurgische
Comparing different treatments
Findings
Alternative therapeutic approaches
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call